Abstract:The main target of the current research is designing and synthesizing novel Co(II) complexes derived from 2-hydroxy-5,3-(phenylallylidene)aminobenzoic acid ligand and to enhance comprehension as potential photocatalyst, antibacterial, antifungal, and antioxidants alternatives by means of using density functional theory (DFT) calculations and molecular docking investigation. Thus, 2-hydroxy-5,3-(phenylallylidene)aminobenzoic acid (L1), was prepared by thermal condensation of cinnamaldehyde with 5-aminosalicylic acid in methanol. A series of cobalt(II) complexes with newly synthesized Schiff base ligand and para substituted phenylphenol (L2) corresponding to complex 1, [Co II (L1) 2 (H 2 O) 4 ], and mixed-ligand complexes, 2 and 3, [Co II (L2) 1/2 (L1)(H 2 O) 4/3 ], have been prepared and analysed by FTIR, 1 H NMR, HRMS, PXRD, electrochemical and fluorescence spectral techniques. DFT calculations were utilized to verify the molecular structure, analysis of Frontier Molecular orbitals (FMOs), molecular electrostatic potential (MEP) and reactivity descriptor for complexes 1–3. In vitro experiments were conducted to evaluate the biological properties of the complexes. These findings revealed that the synthesized metal complexes have heightened biological efficacy as related to the unbound ligand. Complex 2 has been observed to show effective antibacterial MIC value against P. aeruginosa (3.81 μg/mL) which is superior to the efficacy of standard drug chloramphenicol used (7.81 μg/mL) while the antifungal activity of complexes was found to be moderate to that of standard nystatin. Complex 2 has also demonstrated strong antioxidant activity (67.7%), which was on par with ascorbic acid used as a reference. Furthermore, in silico antibacterial activities (molecular docking) of the complexes have indicated these to exhibit excellent efficacy with docking score of − 11.1, − 9.8 and − 9.4 KCalmol −1 against target proteins E. coli (PDB ID: 4OPQ), P. aeruginosa, (PDB ID: 6NE0) and S. aureus, (PDB ID: 3Q89), respectively. The photocatalytic behaviour of the Co(II) based complexes has been studied by Buchwald-Hartwig C–N (BHC) and Suzuki Miyura C–C (SMC) cross coupling reactions. Lastly, a correlation between in vitro efficacies with molecular docking data and photocatalytic activity with DFT data was done and analysed.

Deciphering the effect of hydrophobicity on protein binding interaction in cobalt(II) complexes by multispectroscopic and computational methods

Protein binding and biological evaluation of a polymer-anchored cobalt(III) complex containing a 2,2′-bipyridine ligand

Crystal Structure,Interaction with DNA and BSA and Antiproliferative Activities of Cobalt(Ⅱ) Complex with Demethylcantharate and 2-Aminopyridine

Analysis of the binding mechanism for a water-soluble Pd(II) complex containing β-amino alcohols with HSA applying experimental and computational methods

Deciphering Structural and Dynamical Properties of Hydrated Cobalt Porphyrins via Ab Initio Quantum Mechanical Charge Field Molecular Dynamics Simulation

The Synthesis, Characterization, DNA/protein Interaction, Molecular Docking and Catecholase Activity of Two Co(II) Complexes Constructed from the Aroylhydrazone Ligand

Spectroscopic and Molecular Docking Studies on the Interaction of Human Serum Albumin with Copper(ii) Complexes.

Analysis of Binding Interaction Between Bovine Serum Albumin and the Cobalt(Ii) Complex with Salicylaldehyde-2-Phenylquinoline-4-Carboylhydrazone

Synthesis, Characterisation, Hirshfeld surface analysis, Magnetic susceptibility, DFT calculations, pkCSM profile, and Biological activities of Novel mono‐, di‐, and multinuclear Cobalt (II) complexes

Synthesis, Spectroscopic, Computational Structure Analysis, Molecular Docking, in vitro Antibacterial and in vivo Antipyretic Investigations of Transition Metal(II) Complexes

Synthesis, Crystal Structure, and BSA Interaction with a New Co(II) Complex Based on 5-(Trifluoromethyl)pyridine-2-carboxylic Acid

Spectroscopic Studies on the Binding of Cobalt(II) 1,10-Phenanthroline Complex to Bovine Serum Albumin

Synthesis and crystal structure determination of cobalt(II) mixed-ligand complex containing 1,10-phenanthroline and 5-(2-carboxybenzyloxy)isophthalic acid: Their biological evaluation viz. DNA/protein binding profile, pBR322 DNA cleavage activity

A binuclear Cu(I)-phosphine complex as a specific HSA site I binder: synthesis, X-ray structure determination, and a comprehensive HSA interaction analysis

Impact of hydrogen-bonding interactions on the properties of biomimetic Co2(μ-OH)2 complexes

Synthesis, spectral characterization, protein binding and cytotoxic evaluation of new cobalt(II) and cobalt(III) complexes containing benzimidazolylterpyridine as ligand

A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity.

Interaction Between Three Cobalt(II) Glycollates and Bovine Serum Albumin Studied by Fluorescence Spectrum

Effect of intramolecular hydrogen-bond on the DNA-binding and photocleavage properties of polypyridyl cobalt(III) complexes

Cobalt (II) complex with novel unsymmetrical tetradentate Schiff base (ON) ligand: in vitro cytotoxicity studies of complex, interaction with DNA/protein, molecular docking studies, and antibacterial activity

Design, Spectroscopic Analysis, DFT Calculations, Catalytic Evaluation, and Comprehensive In Silico and In Vitro Bioactivity Studies, Including Molecular Docking, of Novel Co(II) Complexes of 2-Hydroxy-5,3-(phenylallylidene)aminobenzoic Acid